0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Hindustan Times has reported a new India-focused foreign affairs development: “0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines.” The publisher's feed describes the story as follows: In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. Intellectual Janata Party includes this item for public-affairs discovery and context only; readers should use the o
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


